Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$242.49 - $301.46 $4.55 Million - $5.66 Million
18,763 New
18,763 $4.61 Million
Q1 2022

May 16, 2022

SELL
$277.25 - $366.29 $705,046 - $931,475
-2,543 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$300.63 - $371.35 $3.31 Million - $4.09 Million
-11,020 Reduced 81.25%
2,543 $913,000
Q3 2021

Nov 15, 2021

BUY
$310.19 - $376.2 $4 Million - $4.86 Million
12,907 Added 1967.53%
13,563 $4.42 Million
Q2 2021

Aug 16, 2021

SELL
$262.71 - $351.17 $2.2 Million - $2.95 Million
-8,388 Reduced 92.75%
656 $205,000
Q1 2021

May 17, 2021

BUY
$285.92 - $355.13 $2.25 Million - $2.79 Million
7,862 Added 665.14%
9,044 $2.88 Million
Q4 2020

Feb 16, 2021

BUY
$251.88 - $324.2 $297,722 - $383,204
1,182 New
1,182 $383,000
Q1 2020

May 15, 2020

SELL
$130.51 - $196.01 $5.72 Million - $8.58 Million
-43,794 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$159.31 - $223.54 $4.09 Million - $5.74 Million
25,687 Added 141.86%
43,794 $7.47 Million
Q3 2019

Nov 14, 2019

SELL
$175.89 - $279.23 $3.38 Million - $5.36 Million
-19,208 Reduced 51.48%
18,107 $3.22 Million
Q2 2019

Aug 14, 2019

BUY
$250.96 - $284.94 $2.66 Million - $3.02 Million
10,590 Added 39.63%
37,315 $9.72 Million
Q1 2019

May 15, 2019

SELL
$276.39 - $362.25 $186,010 - $243,794
-673 Reduced 2.46%
26,725 $7.63 Million
Q4 2018

Feb 14, 2019

BUY
$281.08 - $444.25 $2.92 Million - $4.61 Million
10,378 Added 60.98%
27,398 $8.91 Million
Q3 2018

Nov 14, 2018

SELL
$354.53 - $449.75 $2.8 Million - $3.55 Million
-7,884 Reduced 31.66%
17,020 $7.66 Million
Q2 2018

Aug 14, 2018

BUY
$278.07 - $446.21 $6.93 Million - $11.1 Million
24,904 New
24,904 $10.2 Million
Q1 2018

May 15, 2018

SELL
$192.49 - $295.85 $1.87 Million - $2.87 Million
-9,709 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$168.78 - $199.74 $1.64 Million - $1.94 Million
9,709
9,709 $1.82 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.